CSPCY 股價走勢圖
CSPCY 收益
CSPC Pharmaceutical Group Limited
$4.15
0.84%
$0.03
收盤價：May 08, 16:00:00 GMT-4
$4.15
0%
$0
盤後：May 08, 20:00:00 GMT-4
返回
CSPC Pharmaceutical Group Limited (CSPCY) 收益
最新獲利結果： Q4 '25
報導： 2026-03-25
歷史收益
每季
年度
EPS
收入
Earnings FAQ
CSPCY 最近的每股盈餘與預期相比如何？
CSPC Pharmaceutical Group Limited CSPCY 上一季度的收入表現如何？
CSPC Pharmaceutical Group Limited 的收入預期是多少？
CSPC Pharmaceutical Group Limited 的盈利品質評分是多少？
CSPC Pharmaceutical Group Limited 何時發布財報？
CSPC Pharmaceutical Group Limited 的預期收益是多少？
CSPC Pharmaceutical Group Limited 是否超出收益預期？
關鍵數據
前收市價
$4.12
開盤價
$4.15
當日範圍
$4.15 - $4.15
52週區間
$2.73 - $5.83
交易量
100
平均成交量
3.5K
股息收益率
--
每股盈餘 (TTM)
0.20
市值
$11.8B
什麼是 CSPC Pharmaceuticals Group Ltd.？
CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 21,400 full-time employees. The firm operates its business through three segments. The Finished Drugs segment in engaged in the research and development, manufacture and sale of pharmaceutical products and licensing business. The Bulk Products segment is engaged in the manufacture and sale of vitamin C, and antibiotic products in bulk powder form. The Functional Food and Others segment is engaged in the manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. The Company’s product therapeutic areas include nervous system, oncology, anti-infectives, cardiovascular, respiratory system, digestion and metabolism and others. The firm conducts its business in the domestic and overseas markets.
